Hunter Capital RTO 1 extends ResoTher Pharma deal talks to Dec. 31, 2026
Hunter Capital RTO 1 has extended its non-binding letter of intent with ResoTher Pharma for a planned reverse acquisition transaction.
Hunter Capital RTO 1 has extended its non-binding letter of intent with ResoTher Pharma for a planned reverse acquisition transaction.